期刊文献+

静脉泵入超剂量甲氨蝶呤致异位妊娠患者急性肾损伤 被引量:1

Acute kidney injury due to venous pumping of overdose methotrexate in an ectopic pregnancy patient
原文传递
导出
摘要 1例36岁异位妊娠患者采用药物保守治疗。医嘱为米非司酮100 mg口服,1次/d,连续3 d;第4天甲氨蝶呤(MTX)80 mg入0.9%氯化钠注射液40 ml静脉泵入。第4天,当班护士未严格核对医嘱,误将规格为1 000 mg/瓶的MTX全部入0.9%氯化钠注射液40 ml并在30 min内静脉泵入。13 h后,患者出现恶心、呕吐、腹痛等症状。2 d后实验室检查示血清肌酐325 μmol/L,尿素氮8.6 mmol/L,尿酸501 μmol/L。考虑为急性肾衰竭,与MTX有关。患者转院并接受血液透析和对症治疗6 d后好转,12 d后复查:血清肌酐73 μmol/L,尿素氮4.1 mmol/L,尿酸363 μmol/L。 A 36-year-old female patient with ectopic pregnancy received conservative treatment with drugs.The doctor ordered oral mifepristone 100 mg once daily for 3 days and then a venous pumping of methotrexate(MTX)80 mg dissolved in 0.9%sodium chloride injection 40 ml.On the 4th day,the nurse on duty did not strictly check the doctor's orders.She mistakenly put a whole bottle of MTX(1000 mg/bottle)into 0.9%sodium chloride injection 40 ml and pumped it intravenously within 30 minutes.Thirteen hours later,the patient developed nausea,vomiting,and abdominal pain.Two days later,the laboratory tests showed serum creatinine 325μmol/L,urea nitrogen 8.6 mmol/L,and uric acid 501μmol/L.Acute kidney failure was considered,which might be related to MTX.The patient was transferred to another hospital and got better after receiving hemodialysis and symptomatic treatments for 6 days.Twelve days later,the reexamination results showed serum creatinine 73μmol/L,urea nitrogen 4.1 mmol/L,and uric acid 363μmol/L.
作者 林菊萍 叶爱菊 Lin Juping;Ye Aiju(Department of Pharmacy,People's Hospital of Sanmen County,Zhejiang Province,Sanmen 317100,China)
出处 《药物不良反应杂志》 CSCD 2020年第11期640-641,共2页 Adverse Drug Reactions Journal
关键词 甲氨蝶呤 妊娠 异位 急性肾损伤 Methotrexate Pregnancy,ectopic Acute kidney injury
  • 相关文献

参考文献4

二级参考文献40

  • 1王大猷.药物治疗错误与医务人员的对策[J].中国药物应用与监测,2004,1(2):1-4. 被引量:9
  • 2Tilyard M, Dovey S, Hall K. Avoiding and fixing medical errors in general practice:prevention strategies reported in the Linnaeus Co- llaboration's Primary Care International Study of Medical Errors [J].NZMedJ, 2005, 118(1208): U1264.
  • 3Kohn LT, Corrigan JM, Donaldson MS. To err is human:building a safer health system [ M ]. Washington, D. C. : National Academy Press, 2000:2.
  • 4中华人民共和国卫生部.医疗机构药事管理规定[EB/OL].(2011-03-30)[2013-04-14].http://www.moh.gov.en/mohyzs/s3585/201103/51113.shtml.
  • 5National Coordinating Council for Medication Error Reporting and Prevention. About Medication Errors E EB/OL ]. ( 2001-02-20 ) [ 2013-11-28 ]. http ://www. nccmerp, org/aboutMedErrors, html.
  • 6Institute for safe medication practices. Frequently asked questions (FAQ) [EB/OL]. [2013-11-28] https://www, ismp. org/faq. asp#Question_2.
  • 7European Medicines Agency. Medication errors[ EB/OL]. [2013- 11-28 ] http://www, ema. europa, eu/ema/index, jsp? curl = pa- ges/special_topics/general/general_content_000570, jsp.
  • 8张晓乐.用药错误:概念、分类和报告现状[N].中国医学论坛报,2011-10-26(A6).
  • 9Ferner RE, Aronson JK. Clarification of terminology in medication errors[ J]. Drug safety, 2006, 29 ( 11 ) : 1011-1022.
  • 10Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug e- vents and potential adverse drug events. Implications for preven- tion. ADE Prevention Study Group [ J ]. JAMA, 1995, 274 ( 1 ) : 29-34.

共引文献202

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部